Sep 27

SS 08 - Kidneys, Bladders, and Breakthroughs

132 - Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

05:00pm - 05:10pm ET

Presenter(s)

Xingzhe Li, MD, MPH - UT Southwestern Medical Center, Dallas, TX